• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer’s Disease | The Journal of Neuropsychiatry and Clinical Neurosciences - 2 hour(s) ago

      Objective: The authors explored classes of neuropsychiatric symptoms (NPSs) in Alzheimer’s disease (AD), examined the relationship between NPS classes on rate of functional decline over time, and determined whether effects of individual symptoms on functional decline remained after controlling for NPS classes. Methods: The authors longitudinally analyzed 9,797 study participants with mild cognitive impairment or AD at baseline in the National Alzheimer’s Coordinating Center Uniform Data Set. Function was measured with the Functional Assessment Questionnaire, and NPSs were assessed by using clinician judgment. Latent class analysis (LCA) was used to identify clusters of individuals who shared similar NPS profiles. Linear mixed models were used to estimate the relationship between NPS classes and individual symptom profiles in functional decline over time. Results: LCA revealed four distinct NPS classes: an asymptomatic-mild group (48.2% of the sample, N=4,721), a second group predominan

      Source: psychiatryonline.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	AmJPsychiatry
        AmJPsychiatry

        Longitudinal examination of neuropsychiatric symptoms (NPS) and functional decline in Alzheimer’s disease (AD) suggests that monitoring individual NPS, particularly apathy, may identify a target for AD treatment in clinical trials. https://t.co/66qhgtlkJB https://t.co/bCceaX8I7D

    • Mashup Score: 8
      Inflammatory Exposure and Depression in Older Adults With Insomnia - 3 hour(s) ago

      This parallel-condition randomized clinical trial determines whether inflammatory exposure induces greater increases in depressive mood and symptoms in older adults with insomnia disorder compared to those without insomnia.

      Source: jamanetwork.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JAMAPsych
        JAMAPsych

        RCT: Older adults with #insomnia have an increased vulnerability to depressive mood and symptoms following inflammatory exposure. https://t.co/rdN7APiQOJ https://t.co/qM4ihYZTeF

    • Mashup Score: 0
      AAPI Youth and Cultural Misalignment | Psychiatric News - 5 hour(s) ago

      PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

      Source: psychiatryonline.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	PsychiatricNews
        PsychiatricNews

        LETTERS TO THE EDITOR | In my extensive work conducting suicide assessments—including bedside evaluations in emergency rooms—I have seen firsthand how these factors shape psychiatric crisis responses, often to the detriment of AAPI youth. https://t.co/8sYUFUAQww https://t.co/Eo5QodmLJs

    • Mashup Score: 0
      Metformin May Curb Weight Gain in Youth Who Take Antipsychotics - 7 hour(s) ago

      Taking metformin may help overweight or obese adolescents who take antipsychotic medications avoid the weight gain commonly associated with…

      Source: alert.psychnews.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	PsychiatricNews
        PsychiatricNews

        Taking metformin may help overweight or obese adolescents who take antipsychotic medications avoid the weight gain commonly associated with the drugs. https://t.co/A1cr6PapeJ https://t.co/1nFjFq7sqL

    • Mashup Score: 28
      New Autism Study Uncovers Four Biological Subtypes - 12 hour(s) ago

      Researchers identified four distinct genetic and clinical subtypes of autism, paving the way for more personalized treatments.

      Source: www.psychiatrist.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	JClinPsychiatry
        JClinPsychiatry

        Researchers identified four distinct genetic and clinical subtypes of autism, paving the way for more precise diagnoses and personalized treatments. https://t.co/zC4OASuFo6

    • Mashup Score: 0
      AMP-Schizophrenia Sites Now Completing Collection of Biomarker Data | Psychiatric News - 22 hour(s) ago

      PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

      Source: psychiatryonline.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	PsychiatricNews
        PsychiatricNews

        AMP-SCZ is gathering an enormous amount of data on sleep, mobility, exercise, and speech patterns as well as genetic, electrophysiological, and brain imaging data as potential biomarkers for psychosis. https://t.co/wrv5nOu9cF https://t.co/A0S0vhS05w

    • Mashup Score: 2
      Emerging Treatments for Residual Symptoms of Major Depressive... - 23 hour(s) ago

      Other event by Medscape on Friday, June 27 2025

      Source: www.facebook.com
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	MedscapePsych
        MedscapePsych

        ICYMI! Residual symptoms in MDD deserve attention. Our experts break down why insomnia can be more than just a side effect. Watch the full live stream to find out what’s working - and what’s emerging 👉 https://t.co/GZKTRp2pB3 #CME https://t.co/C5Ks7uhFr8

    • Mashup Score: 0
      Study Derives Optimal Payment Incentives for Contingency Management - 1 day(s) ago

      Effective contingency management (CM) programs for stimulant and/or opioid use disorder have median inflation-adjusted payment incentives o…

      Source: alert.psychnews.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	PsychiatricNews
        PsychiatricNews

        While CM programs have more than 40 years of research support, they are not widely used in the United States. https://t.co/qjk5stcB5D https://t.co/JcD5ESBiUi

    • Mashup Score: 3
      Cognitive Impairment and Problematic Internet Use | American Journal of Psychiatry - 1 day(s) ago

      PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

      Source: psychiatryonline.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	AmJPsychiatry
        AmJPsychiatry

        An AJP Editorial discusses cognitive impairment and problematic Internet use. https://t.co/qD58eqrIte https://t.co/O9vdOzEM1l

    • Mashup Score: 1
      Med Check: FDA Clears At-Home Calming Device for Teens, Azetukalner Advances to Phase 3, and More | Psychiatric News - 1 day(s) ago

      PsychiatryOnline.org is the platform for all American Psychiatric Association Publishing journals, DSM, and bestselling textbooks, as well as APA Practice Guidelines, and continuing medical education.

      Source: psychiatryonline.org
      Categories: General Medicine News, Psychiatry
      Tweet Tweets with this article
      • Profile photo of 	PsychiatricNews
        PsychiatricNews

        MEDCHECK | In January, the Centers for Medicare and Medicaid Services introduced reimbursement codes for FDA-cleared digital mental health treatments, clearing the way for patient reimbursement for devices such as Freespira. https://t.co/tO1sOLYGdY https://t.co/42EeK6ijXM

    Load More
    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings